Tetsuhide Ito

5PUBLICATIONS
0CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2023
Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.

Tetsuhide Ito, Irene Ramos-Alvarez, Robert T Jensen

|Oct 20, 2022
A case of erythema multiforme-like rash induced by everolimus in a patient with a pancreatic neuroendocrine tumor.

Yuji Mizuno, Tetsuhide Ito, Keijiro Ueda

|Sep 29, 2021
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.

Tetsuhide Ito, Toshihiko Masui, Izumi Komoto

|Aug 07, 2020
Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.

Tetsuhide Ito, Nao Fujimori, Yoshitaka Honma

|Oct 19, 2019
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito

Pageof 1

Frequent Collaborators